Detailed Information on Publication Record
2024
Truncated vitronectin with e-cadherin enables the xeno-free derivation ofhuman embryonic stem cells
SOURALOVÁ, Tereza, Daniela HULÍNOVÁ, Pavel VENTRUBA, Michal JEŠETA, Aleš HAMPL et. al.Basic information
Original name
Truncated vitronectin with e-cadherin enables the xeno-free derivation ofhuman embryonic stem cells
Authors
Edition
23rd Interdisciplinary Meeting of Young Biologists, Biochemists, and Chemists, Milovy, 2024
Other information
Language
English
Type of outcome
Prezentace na konferencích
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Tags
Reviewed
Změněno: 24/5/2024 11:01, Mgr. Tereza Souralová
Abstract
V originále
Human embryonic stem cells (hESCs) are able to differentiate into any cell type of a human body, have self-renewal abilities and very high proliferative activity1. These unique abilities enable their use in cell therapy, disease modelling, and drug development. The derivation of hESCs is usually performed using an animal or human cell feeder layer, which is undefined and potentially contagious, and because of these difficulties, there is a tendency to replace feeders with xeno-free defined substrates in recent years2.We used truncated vitronectin with E-cadherin as adefined xeno-free substrate for the derivation of hESCs for the first time, derived three hESC lines, and confirmed their undifferentiated state, hESC morphology, and standard karyotypes together with their potential to differentiate into three germ layers (ectoderm, mesoderm, and endoderm)3. We confirmed for the first time that truncated vitronectin with E-cadherin is a defined xeno-free substrate that is suitable for the derivation of hESCs involved in cell therapies.
Links
MUNI/A/1301/2022, interní kód MU |
| ||
MUNI/A/1598/2023, interní kód MU |
| ||
MUNI/IGA/1332/2021, interní kód MU |
| ||
NU22-08-00629, research and development project |
|